Vanderbilt Kennedy Center

Medication study for adult males with Autism Spectrum Disorder

Last Updated: Monday, November 04, 2013

Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.

Other researchers: Kevin Sanders, MD

Description

We are seeking adult males age 18– 45 with autism spectrum disorder for a study using an investigational drug called RO5285119 – it is an investigational vasopressin antagonist.

The purpose of the study is to try and find out if this medication is safe and helpful in treating social and communication deficits found in patients with an autism spectrum disorder.

Evaluations, study visits, and study drug are provided at no cost.

You will be asked to come for up to 16 visits to Vanderbilt University in Nashville, TN to take part in this research study. There may be an opportunity for a nurse to come to your home for some of these visits. A blood draw is required at most visits.

This study is sponsored by Roche Pharmaceuticals.

Participant Criteria

Males ages 18-45 with diagnosis of autism spectrum disorder. Must be verbal.

Compensation

$50 per site visit

Visit Requirements

6 visits to Vanderbilt University, plus 10 in-home visits

Brochure

Download Brochure

Contact Information

Sarah Marler
615 936 3288
sarah.marler@vanderbilt.edu

Want to Participate in this Study?

Enter your name and contact information and this study's coordinators will contact you if there are openings available.

 
 
(Optional)